Elenco degli articoli con argomento «carcinoma basocellulare»


05 feb 2024

Final analysis of phase II results with cemiplimab

Metastatic basal cell carcinoma (mBCC) is a rare condition with no effective second-line treatment options

24 gen 2024

Il carcinoma al viso, Paola Ferrari come si interviene navigation-next-alternate

La giornalista Paola Ferrari ha parlato di un nuovo basalioma, un carcinoma al viso, che l'aveva già costretta a un primo intervento chirurgico. Si opererà di nuovo. Di cosa si tratta e come si cura

05 set 2022

Curettage vs. cryosurgery for superficial basal cell carcinoma

Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence.

11 lug 2022

Line-Field Confocal Optical Coherence

Diagnosing clinically unclear basal cell carcinomas (BCCs) can be challenging.

16 mag 2022

Curettage versus cryosurgery for superficial basal cell carcinoma

Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence.

10 mag 2022

BCC AVANZATO navigation-next-alternate

Studio osservazionale retrospettivo e prospettico sui pazienti affetti da carcinoma basocellulare avanzato

29 apr 2022

Unusual dermoscopic patterns

Basal cell carcinoma can simulate melanoma and specific dermoscopic criteria have not yet been defined in a large cohort

28 feb 2022

How to spot a basosquamous carcinoma

Basosquamous carcinoma (BSC) is a relatively rare type of neoplasm originating from basal cell carcinoma with features of squamous differentiation.

24 gen 2022

Position paper on a simplified histopathological classification of basal cell carcinoma

Histopathological classification of basal cell carcinoma (BCC) has important prognostic and therapeutic implications, but reproducibility of BCC subtyping among dermatopathologists is poor.

26 ago 2021

Position statement on Classification of Basal Cell Carcinomas

No simple staging system has emerged for basal cell carcinomas (BCCs)

26 ago 2021

Position statement on classification of basal cell carcinomas

No simple classification system has emerged for 'advanced basal cell carcinomas', and more generally for all difficult-to-treat BCCs

13 apr 2021

Clinical and Dermoscopic Factors

Infiltrative basal cell carcinoma (BCC) has a higher risk for post-surgical recurrence as compared to the most common low-aggressive superficial and nodular BCC.

20 ott 2020

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?

06 ott 2020

Systematic Review of Mohs Micrographic Surgery in Children

Identifying Challenges and Practical Considerations for Successful Application

18 mag 2020

Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells

Photodynamic Therapy (PDT) with methyl-aminolevulinate (MAL-PDT) is being used for the treatment of Basal Cell Carcinoma (BCC), although resistant cells may appear.

26 apr 2020

Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas

patient‐reported outcomes from the MIKIE study

06 apr 2020

Presurgical evaluation of basal cell carcinoma using combined reflectance confocal microscopy–optical coherence tomography

A prospective study

17 dic 2019

Sex-stratified polygenic risk score identifies individuals at increased risk of basal cell carcinoma

The incidence of basal cell carcinoma (BCC) is higher among men than women.

17 set 2019

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines

Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatment of Cancer collaborated to develop recommendations on diagnosis and treatment of BCC. A new classification into 'easy-to-treat (common) BCC and 'difficult-to-treat' BCC is proposed.

22 mag 2019

Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic navigation-next-alternate

Organ transplant recipients (OTR) have a higher risk of developing cutaneous squamous cell carcinoma (cSCC) compared to the immunocompetent population. Immunosuppression is often stated as a risk factor for metastasis. However, evidence for this is scarce. Objectives